BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1950750)

  • 1. The prevalence of the deletion F508 in a Belgian cystic fibrosis population.
    Lissens W; Bonduelle M; Malfroot A; Dab I; Liebaers I
    Adv Exp Med Biol; 1991; 290():369-70. PubMed ID: 1950750
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of the delta F508 deletion of the cystic fibrosis gene in Belgian patients.
    Cochaux P; van Geffel R; Baran D; Poncin J; Vassart G
    Hum Genet; 1990 Sep; 85(4):400. PubMed ID: 2210745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deletion F508 is the major gene mutation in a representative Belgian cystic fibrosis population.
    Bonduelle M; Lissens W; Malfroot A; Dab I; Liebaers I
    Hum Genet; 1990 Sep; 85(4):395-6. PubMed ID: 2210742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between XV2c/CS7/KM19/D9 haplotypes and the delta F508 mutation. A study of 57 Belgian families.
    Cuppens H; Legius E; Cabello P; Marynen P; De Boeck C; Decorte R; Fryns JP; Eggermont E; Van den Berghe H; Cassiman JJ
    Hum Genet; 1990 Sep; 85(4):402-3. PubMed ID: 2210747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of the phenylalanine deletion (delta F508) in the CF gene of Belgian cystic fibrosis patients.
    Wauters JG; Hendrickx J; Coucke P; Vits L; Stuer K; van Schil L; van der Auwera BJ; Van Elsen A; Dumon J; Willems PJ
    Clin Genet; 1991 Feb; 39(2):89-92. PubMed ID: 1673094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The delta F508-deletion in 99 CF patients of Switzerland.
    Liechti-Gallati S; Parsai I; Kraemer R; Rudeberg A; Braga S; Moser H
    Adv Exp Med Biol; 1991; 290():367-8. PubMed ID: 1950749
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequency of the delta F508 mutation in a sample of 175 Italian cystic fibrosis patients.
    Cremonesi L; Ruocco L; Seia M; Russo S; Giunta A; Ronchetto P; Fenu L; Romano L; Devoto M; Romeo G
    Hum Genet; 1990 Sep; 85(4):400-2. PubMed ID: 2210746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the major mutation of the CF gene in Belgian patients.
    Cochaux P; Van Geffel R; Baran D; Vassart G
    Adv Exp Med Biol; 1991; 290():353-4. PubMed ID: 1950745
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystic fibrosis delta F508 mutation in a French population.
    Lucotte G; Barre E
    Adv Exp Med Biol; 1991; 290():371-2. PubMed ID: 1950751
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency of the delta-F508 mutation and flanking marker haplotypes at the cystic fibrosis locus from 167 Czech families.
    Macek M; Vavrova V; Boehm I; Stuhrmann M; Reis A; Macek M; Duspisova R; Jelinkova E; Sperling K; Krawczak M
    Adv Exp Med Biol; 1991; 290():373-5. PubMed ID: 1950752
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystic fibrosis in the Portuguese population: haplotype distribution and molecular pathology.
    Duarte A; Barreto C; Marques-Pinto L; Tavares MC; Amil J; Pinto M; Chieira ML; Castedo S; Lavinha J
    Hum Genet; 1990 Sep; 85(4):404-5. PubMed ID: 2210749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of the deletion of the delta F508 gene in cystic fibrosis].
    Fernández García E; Nunes Martínez V; Ibáñez Olias MA; Benítez Ortíz J
    An Esp Pediatr; 1991 Nov; 35(5):307-8. PubMed ID: 1785742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The delta F508 mutation in Israeli CF families.
    Lerer I; Cohen S; Chemke M; Friedmen A; Abeliovich D
    Adv Exp Med Biol; 1991; 290():365-6. PubMed ID: 1950748
    [No Abstract]   [Full Text] [Related]  

  • 14. First analysis of the F508 deletion in cystic fibrosis patients from the GDR.
    Grade K; Will K; Szibor R; Gedschold J; Brückner R; Bauer I; Giermann K; Gorki H; Hein J; Brell U
    Hum Genet; 1990 Sep; 85(4):406-7. PubMed ID: 1976592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of 22 cystic fibrosis mutations in 62 patients from the Flanders, Belgium, reveals a high prevalence of Nordic mutation 394delTT.
    Messiaen L; Van Loon C; Rossau R; De Canck I; De Baets F; Robbrecht E; De Paepe A
    Hum Mutat; 1997; 10(3):236-8. PubMed ID: 9298825
    [No Abstract]   [Full Text] [Related]  

  • 16. Cystic fibrosis. Part I. Frequency of the delta F508 mutation in South African families with cystic fibrosis.
    Denter M; Ramsay M; Jenkins T
    S Afr Med J; 1992 Jul; 82(1):7-10. PubMed ID: 1641732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis at the cystic fibrosis locus in the British population.
    Harris A; Beards F; Mathew C
    Hum Genet; 1990 Sep; 85(4):408-9. PubMed ID: 2210751
    [No Abstract]   [Full Text] [Related]  

  • 18. [The frequency of F508 deletion of the mucoviscidosis gene in patients and in families at high risk in Soviet populations].
    Baranov VS; Ivashchenko TE; Gorbunova VN; Dean M
    Dokl Akad Nauk SSSR; 1990; 313(2):446-8. PubMed ID: 2149699
    [No Abstract]   [Full Text] [Related]  

  • 19. Cystic fibrosis in Greece: typing with DNA probes and identification of the common molecular defect.
    Balassopoulou A; Loukopoulos D; Kollia P; Devoto M; Adam G; Arvanitakis S; Hadjisevastou H
    Hum Genet; 1990 Sep; 85(4):393-4. PubMed ID: 2210741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of cystic fibrosis in Maritime Canada.
    Corsten PG; Blight CE; Riddell DC; Hamilton DC; Cole DE
    Clin Invest Med; 1994 Feb; 17(1):1-8. PubMed ID: 7909728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.